We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The initial response to the FDA’s trial opening of its Customer Collaboration Portal to premarket device submissions has been encouraging, the agency says. Read More
It’s possible to detect the potentially stroke-inducing cardiac condition atrial fibrillation effectively and more cheaply using wearable devices, according to researchers at Harvard Medical School and Massachusetts General Hospital. Read More
Omaha, Neb.-based medical imaging software company Bot Image has received FDA clearance for its ProstatID tool, a cloud-based artificial intelligence (AI) software product that helps detect and diagnose prostate cancer. Read More
Cognito Therapeutics’ gamma sensory stimulation therapy reduced white matter atrophy in the brains of patients with Alzheimer’s disease in a six-month study, the company announced at the Alzheimer’s Association International Conference 2022 in San Diego. Read More